COCP: Cocrystal Pharma, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-07 | New 13D stake | OPKO HEALTH, INC. | 29.60% | SEC | |
| 2026-08-07 | 13D amendment | Phillip Frost, M.D. | 13.90% | SEC |
Institutional ownership (Q2 2026)
28 institutions reported holding $1.15M of Cocrystal Pharma, Inc. on Form 13F (26 the quarter before). 5 opened a new position and 5 sold out. Shares held by institutions: +43%.
| Largest holders | Shares | Value |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 358,228 | $376K |
| RENAISSANCE TECHNOLOGIES LLC | 179,628 | $189K |
| TWO SIGMA INVESTMENTS, LP | 175,379 | $184K |
| GEODE CAPITAL MANAGEMENT, LLC | 76,208 | $80K |
| BlackRock, Inc. | 73,746 | $77K |
| CITADEL ADVISORS LLC | 45,118 | $47K |
| NEUBERGER BERMAN GROUP LLC | 31,886 | $33K |
| XTX Topco Ltd | 29,342 | $31K |
| JANE STREET GROUP, LLC | 25,761 | $27K |
| VANGUARD FIDUCIARY TRUST CO | 24,016 | $25K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.